Georgetown Angels, a premier angel group, invests in Later Stage Seed and Series A & B venture capital financing rounds of early stage disruptive technology companies.
We leverage our global network of accredited angel investors and advisors enabling our portfolio companies access to capital and strategic relationships resulting in partnerships, talent, advisory boards, key customer introductions and leading venture capital firms for follow on funding.
Our angels benefit from high quality proprietary and shared deal flow, due diligence from subject matter experts and our executive level contacts, pooled capital, term sheets, valuation, legal structures and a fund mechanism to invest, on a deal-by-deal basis, in selected best in class startups per quarter.
Georgetown Angels is open to all startup companies and accredited investors. Interested angels may contact us for membership here.
Encouraging and enabling direct contact between our angels and our portfolio companies and recruiting the best advisors to make our portfolio companies successful in both fundraising and execution are all top priorities. Sharing deal flow, due diligence and syndicating with early stage VCs, local and national angel groups, and independent strategic investors is a unique aspect that we employ to insure all our selected companies receive the proper funding, relationship and customer commitments.
Please inquire about our upcoming Healthcare IT event (January) in San Francisco and SXSW in March